Drug survival and post-drug survival of first-line immunosuppressive treatments for atopic dermatitis: Comparison between methotrexate and cyclosporine
Journal of the European Academy of Dermatology and Venereology | Feb 22, 2018
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial
Journal of the American Academy of Dermatology | Feb 21, 2018
Secukinumab demonstrates high sustained efficacy and a favorable safety profile in patients with moderate to severe psoriasis through 5 years of treatment (SCULPTURE extension study)
Journal of the European Academy of Dermatology and Venereology | Feb 20, 2018
Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis
Journal of the American Academy of Dermatology | Feb 16, 2018